Diamedica Therapeutics Stock Technical Analysis
| DMAC Stock | USD 2.42 0.09 3.59% |
As of the 25th of April, DiaMedica Therapeutics shows the Mean Deviation of 2.73, coefficient of variation of (2,108), and Standard Deviation of 3.57. DiaMedica Therapeutics technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to analyze thirteen technical drivers for DiaMedica Therapeutics, which can be compared to its peers. Please confirm DiaMedica Therapeutics information ratio, potential upside, and the relationship between the standard deviation and maximum drawdown to decide if DiaMedica Therapeutics is priced favorably, providing market reflects its regular price of 2.42 per share. Please also check DiaMedica Therapeutics jensen alpha, which is currently at (0.19) to verify the company can sustain itself at a future point.
DiaMedica Therapeutics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as DiaMedica, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to DiaMedicaDiaMedica |
DiaMedica Therapeutics Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 8.33 | Strong Buy | 2 | Odds |
Most DiaMedica analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand DiaMedica stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of DiaMedica Therapeutics, talking to its executives and customers, or listening to DiaMedica conference calls.
DiaMedica Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
DiaMedica Therapeutics Technical Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of DiaMedica Therapeutics volatility. High ATR values indicate high volatility, and low values indicate low volatility.
DiaMedica Therapeutics Trend Analysis
Use this graph to draw trend lines for DiaMedica Therapeutics. You can use it to identify possible trend reversals for DiaMedica Therapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual DiaMedica Therapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.DiaMedica Therapeutics Best Fit Change Line
The following chart estimates an ordinary least squares regression model for DiaMedica Therapeutics applied against its price change over selected period. The best fit line has a slop of 0.0091 , which may suggest that DiaMedica Therapeutics market price will keep on failing further. It has 122 observation points and a regression sum of squares at 3.15, which is the sum of squared deviations for the predicted DiaMedica Therapeutics price change compared to its average price change.About DiaMedica Therapeutics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of DiaMedica Therapeutics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of DiaMedica Therapeutics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on DiaMedica Therapeutics price pattern first instead of the macroeconomic environment surrounding DiaMedica Therapeutics. By analyzing DiaMedica Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of DiaMedica Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to DiaMedica Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2021 | 2023 | 2024 (projected) | Payables Turnover | 0.0472 | 0.0324 | 0.027 | Days Of Inventory On Hand | 1.7K | 1.5K | 912.5 |
DiaMedica Therapeutics April 25, 2024 Technical Indicators
Most technical analysis of DiaMedica help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for DiaMedica from various momentum indicators to cycle indicators. When you analyze DiaMedica charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.02) | |||
| Market Risk Adjusted Performance | (2.22) | |||
| Mean Deviation | 2.73 | |||
| Coefficient Of Variation | (2,108) | |||
| Standard Deviation | 3.57 | |||
| Variance | 12.74 | |||
| Information Ratio | (0.07) | |||
| Jensen Alpha | (0.19) | |||
| Total Risk Alpha | (0.62) | |||
| Treynor Ratio | (2.23) | |||
| Maximum Drawdown | 16.64 | |||
| Value At Risk | (5.94) | |||
| Potential Upside | 5.36 | |||
| Skewness | 0.5428 | |||
| Kurtosis | 0.5901 |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DiaMedica Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. For information on how to trade DiaMedica Stock refer to our How to Trade DiaMedica Stock guide.Note that the DiaMedica Therapeutics information on this page should be used as a complementary analysis to other DiaMedica Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Complementary Tools for DiaMedica Stock analysis
When running DiaMedica Therapeutics' price analysis, check to measure DiaMedica Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DiaMedica Therapeutics is operating at the current time. Most of DiaMedica Therapeutics' value examination focuses on studying past and present price action to predict the probability of DiaMedica Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DiaMedica Therapeutics' price. Additionally, you may evaluate how the addition of DiaMedica Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |
Is DiaMedica Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DiaMedica Therapeutics. If investors know DiaMedica will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DiaMedica Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.60) | Return On Assets (0.30) | Return On Equity (0.47) |
The market value of DiaMedica Therapeutics is measured differently than its book value, which is the value of DiaMedica that is recorded on the company's balance sheet. Investors also form their own opinion of DiaMedica Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is DiaMedica Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DiaMedica Therapeutics' market value can be influenced by many factors that don't directly affect DiaMedica Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DiaMedica Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if DiaMedica Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DiaMedica Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.